S8 Ep4: Bringing CAR T and Bispecifics to the Community
Andrew Dalovisio, MD, a hematologist/oncologist at Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana, discusses how his community cancer center built a CAR T and bispecific antibody program from the ground up. He walks through the toxicities associated with these T-cell–engaging therapies, including cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS), and explains how prophylactic measures and a robust home-monitoring program have made outpatient management feasible. Dalovisio also addresses disparities in access, including insurance…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.